Loading...
SeniorFull-timeGit
Salary Range
$49,725 - $67,275 /year
This salary is estimated based on similar roles. The actual salary may vary.
About the Role
We are looking for a Brand Manager to shape launch strategy and serve as the strategic and operational driver for products throughout their lifecycle. This role requires leading cross-functional collaboration and execution of launch plans.
Key Responsibilities
- βLead launch and lifecycle strategy for FCS and sHTG, translating global strategy into effective local execution
- βDrive cross-functional collaboration with Medical, Market Access, Sales, Regulatory and global teams
- βOwn brand leadership and planning, including annual brand plan, promotional strategy, congresses, and customer-facing educational initiatives
- βLeverage insights, analytics and performance data to guide decision-making and monitor brand performance
- βEnsure compliant execution of all activities in line with regulatory requirements
Requirements
- βExperience in brand management and product lifecycle
- βStrong leadership and cross-functional collaboration skills
- βAbility to translate global strategy into local execution
- βKnowledge of regulatory requirements and internal governance standards
- βExperience with performance data analysis and ROI evaluation
Benefits
- β Opportunity to shape launch strategy and drive product lifecycle
- β Role involves occasional unsociable hours, weekend working, and overnight stays for key meetings
- β Hybrid role with 1 day per week minimum at the UK office in Cambridge
Free to sign up. Takes 30 seconds.
About Sobi
Sobi is a global specialty biopharmaceutical company focused on developing and delivering innovative therapies for patients with rare and severe diseases. Headquartered in Sweden, the company has established a strong presence in the life sciences industry, leveraging its expertise to address unmet medical needs. Founded with a commitment to improving patient outcomes, Sobi has grown into a leader in the rare disease sector, operating across multiple countries to bring life-changing treatments to those who need them most. Sobiβs main products and services include the development, manufacturing, and commercialization of specialty medicines, with a particular emphasis on hematology, immunology, and rare diseases. The companyβs portfolio features therapies that target conditions such as hemophilia, immunoglobulin deficiencies, and inherited metabolic disorders. Key features of Sobiβs offerings include advanced treatment options, personalized care approaches, and robust patient support programs. The company primarily serves patients, healthcare providers, and institutions, focusing on communities affected by rare and complex conditions. Notable achievements include the successful launch of several breakthrough therapies and strategic acquisitions that have expanded Sobiβs capabilities and market reach. The company is recognized for its innovative research and patient-centric approach, positioning it as a trusted partner in the rare disease community. Sobiβs unique value proposition lies in its dedication to rare diseases, combining scientific excellence with a deep understanding of patient and caregiver needs to deliver meaningful treatments.
